Neutralizing and binding activities against SARS‐CoV ‐1/2, MERS‐CoV , and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

(2020)   Nature Microbiology

Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens

(2020) José-María Díez et al.   Immunotherapy

Deployment of convalescent plasma for the prevention and treatment of COVID-19

(2020) Evan M. Bloch et al.   JOURNAL OF CLINICAL INVESTIGATION

Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19

(2020) Yun Xie et al.   JOURNAL OF INFECTION

Convalescent plasma transfusion for the treatment of COVID‐19: Systematic review

(2020) Karthick Rajendran et al.   JOURNAL OF MEDICAL VIROLOGY

High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019

(2020) Wei Cao et al.   Open Forum Infectious Diseases

Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!

(2020) Alan A. Nguyen et al.   CLINICAL IMMUNOLOGY

The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis

(2014) John Mair-Jenkins et al.   JOURNAL OF INFECTIOUS DISEASES

Hyperimmune IV Immunoglobulin Treatment

(2013) Ivan F.N. Hung et al.   CHEST

Differences in neutralizing antigenicity between laboratory and clinical isolates of HCoV-229E isolated in Japan in 2004-2008 depend on the S1 region sequence of the spike protein

(2012) K. Shirato et al.   JOURNAL OF GENERAL VIROLOGY

Significant neutralizing activity of human immunoglobulin preparations against pandemic 2009 H1N1

(2009) Mikihiro Yunoki et al.   BRITISH JOURNAL OF HAEMATOLOGY

Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a U.S. Metropolitan Population

(2008) E. G. Severance et al.   Clinical and Vaccine Immunology